Go to deals
TMT

Ultrasist has been acquired by Intellego Consulting

The private shareholders of Ultrasist have sold the company to Intellego Consulting for US$12 million.

Ultrasist is an IT consulting company. It offers audit and quality assurance consulting, software development, training and business analysis.

Intellego Consulting, an IT consulting company, specializes in information, processes, and IT management solutions in Latin America and the United States. It offers information management services such as information management strategy, data management, content management, business intelligence, advanced analytics and enterprise performance management solutions.

Oaklins' team in Mexico acted as the exclusive financial advisor to the seller in this transaction.

Parties

Talk to the deal team

Arseny Lepiavka

Managing Partner
Mexico City, Mexico
Oaklins ZIMMA

Related deals

BodhiCedric has acquired Network Media from Jellysmack
TMT

BodhiCedric has acquired Network Media from Jellysmack

The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.

Learn more
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Learn more
Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more